Non‐selective dampening of the host immune response after hepatitis C clearance and its association with circulating chemokine and endotoxin levels
Liver International · 2023
DOI: 10.1111/liv.15737 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2023. Verfasst von Gabriella Quinn und 18 weiteren Autor:innen. Beteiligte Einrichtung: Translational Hepatology Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland…. Hauptthemen laut MEDLINE: Hepatitis C, Chronic, Hepatitis C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Background & Aims Direct‐acting antiviral (DAA) therapy has revolutionized treatment for the hepatitis C virus (HCV). While DAA therapy is common, little is known about the intrahepatic immunological changes after sustained virologic response (SVR). We aim to describe transcriptional alterations of the gut microbiome and the liver after SVR.
Methods
Twenty‐two HCV patients were evaluated before and 9 months after 12 weeks of sofosbuvir/velpatasvir treatment. All achieved SVR. A liver biopsy, portal blood (direct portal vein cannulation), peripheral blood and stool samples were obtained. RNA‐seq and immunofluorescent staining were performed on liver biopsies. RNA‐seq and 16S rRNA metagenomics were performed on stool.
Results
Differential expression within liver transcription showed 514 downregulated genes (FDR q < .05; foldchange > 2) enriched in inflammatory pathways; of note, GO:0060337, type 1 IFN signalling ( p = 8e‐23) and GO:0042742, defence response to bacterium ( p = 8e‐3). Interestingly, microbial products increased in the portal blood and liver after SVR. Due to the increase in microbial products, the gut microbiome was investigated. There was no dysbiosis by Shannon diversity index or Bacteroides/Firmicutes ratio. There was a differential increase in genes responsible for bacterial lipopolysaccharide production after SVR.
Conclusions
The decrease in the antiviral interferon pathway expression was expected after SVR; however, there was an unanticipated decrease in the transcription of genes involved in recognition and response to bacteria, which was associated with increased levels of microbial products. Finally, the alterations in the function of the gut microbiome are a promising avenue for further investigation of the gut‐liver axis, especially in the context of the significant immunological changes noted after SVR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Hepatology Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
- Immunology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
- NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
- Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
- Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
ORCID-Profile: Gabriella Quinn, Kareen Hill, Elizabeth Townsend, Christopher Koh, Ohad Etzion
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- NIH Clinical Center
Zitieren
APA
Quinn, G., Ali, R. O., Zhang, G. Y., Hill, K., Townsend, E., Umarova, R., Chakraborty, M., Ahmad, M. F., Gewirtz, M., Haddad, J., Rosenzweig, S., Rampertaap, S., Schoenfeld, M., Yang, S., Koh, C., Levy, E., Kleiner, D. E., Etzion, O., & Heller, T. (2023). Non‐selective dampening of the host immune response after hepatitis C clearance and its association with circulating chemokine and endotoxin levels. Liver International. https://doi.org/10.1111/liv.15737
Vancouver
Quinn G, Ali RO, Zhang GY, Hill K, Townsend E, Umarova R, et al. Non‐selective dampening of the host immune response after hepatitis C clearance and its association with circulating chemokine and endotoxin levels. Liver International. 2023. doi:10.1111/liv.15737
BibTeX
@article{Quinn2023,
author = {Quinn, Gabriella and Ali, Rabab O and Zhang, Grace Y and Hill, Kareen and Townsend, Elizabeth and Umarova, Regina and Chakraborty, Moumita and Ahmad, Maleeha F and Gewirtz, Meital and Haddad, James and Rosenzweig, Sergio and Rampertaap, Shakuntala and Schoenfeld, Megan and Yang, Shanna and Koh, Christopher and Levy, Elliot and Kleiner, David E and Etzion, Ohad and Heller, Theo},
title = {Non‐selective dampening of the host immune response after hepatitis C clearance and its association with circulating chemokine and endotoxin levels},
journal = {Liver International},
year = {2023},
doi = {10.1111/liv.15737}
}
EUVIMED